IMUX
Immunic·NASDAQ
--
--(--)
--
--(--)
3.78 / 10
Netural
Fund flow is strong (7.56/10) with positive small‑cap inflows, yet analyst coverage is minimal—only one Strong Buy from Guggenheim and a 0% historical win rate. The stock is down 6% and market sentiment is neutral, creating mixed signals.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-24
InstitutionGuggenheim
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for IMUX?
- IMUX holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.78/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
